Making Sense of Diseases in the Field
When millions of humans and animals are on the verge of being exposed to highly contagious and dangerous diseases – time is of the essence. Disease detecting techniques like SERS (Surface-Enhanced Raman Spectroscopy), used in a laboratory setting, allow for a higher degree of sensitivity in detection, but the tradeoff for this is a loss of time – potentially leading to heavy losses in cost, health, and lives.
The recent outbreak in H5N1 (Bird flu) highlights the need for ultra-sensitive, speedy, onsite detection methods in order to identify a full-blown outbreak before it occurs. And with a contagion like Bird flu, which is able to jump species with deadly results, an onsite, easy-to-use SERS unit could be both a business saver and lifesaver.
The idea behind SERS is using an object’s reaction to light. At the University of North Carolina at Chapel Hill’s Freeman Lab, along with partners at Ohio State University, a handheld SERS technique was developed in which a peptide strand, designed to capture a specific virus’ spike signature, is attached to gold nanoparticles. Once the peptide strand has captured the virus, a laser is shone which will reflect the light and indicate if the target virus is present.


This technology has the potential to not only capture and detect SARS-Cov-2, but virtually any virus in trace amounts, accurately, and with minimal training.
The sample is taken – in the case of Bird flu, via stool – it is then mixed with the gold-particle-peptide solution, and a drop is taken and placed on a slip. A laser is then shone onto the sample and the reading is taken. The ability to detect a disease like Bird flu on a farm, in real time, could allow flocks to be isolated, prevent spread, or rule out infection; potentially saving millions of dollars in the process.
The Freeman Lab has also developed a general public directed disease sensor – Glycogrip. This technology is a robust, user-friendly, multi-disease-detection package, capable of being used by anyone, and in less-than-favorable conditions.
Come back for more news from the Freeman Lab!
If you would like to learn more about partnering with us regarding this technology, please reach out!
Taylor D Payne, Stephen J. Klawa, Tengyue Jian, Qunzhao Wang, Sang Hoon Kim, Ronit Freeman, and Zachary D. Schultz
Sensors and Diagnostics, 2023